Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-01 @ 4:18 PM
Study NCT ID:
NCT06010004
Status:
COMPLETED
Last Update Posted:
2025-07-14
First Post:
2023-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-05
Completion Date Type:
ACTUAL
First Submit Date:
2023-08-21
First Submit QC Date:
None
Study First Post Date:
2023-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-11
Last Update Post Date:
2025-07-14
Last Update Post Date Type:
ACTUAL